Opko Health, Inc. OPK
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.93% | 4.32% | -17.18% | -19.16% | -67.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.93% | 4.32% | -17.18% | -19.16% | -67.50% |
| Cost of Revenue | 5.35% | -15.26% | -22.10% | -9.43% | -85.29% |
| Gross Profit | 23.69% | 145.81% | 40.56% | -42.37% | 186.57% |
| SG&A Expenses | 11.53% | -11.20% | -17.74% | -16.12% | -77.32% |
| Depreciation & Amortization | -0.49% | -2.44% | -4.51% | -6.34% | -19.06% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.61% | -12.99% | -19.30% | -11.18% | -67.97% |
| Operating Income | 6.39% | 58.25% | 24.05% | -34.68% | 68.72% |
| Income Before Tax | -4.63% | 91.76% | 16.93% | -234.15% | -184.62% |
| Income Tax Expenses | 9.20% | 64.61% | -5.89% | -174.77% | -134.22% |
| Earnings from Continuing Operations | -8.01% | 94.33% | 18.88% | -322.83% | -232.26% |
| Earnings from Discontinued Operations | -132.96% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -347.49% | 94.33% | 18.88% | -322.83% | -13.09% |
| EBIT | 6.39% | 58.25% | 24.05% | -34.68% | 68.72% |
| EBITDA | 19.72% | 92.87% | 34.03% | -161.32% | 86.99% |
| EPS Basic | -357.91% | 94.11% | 28.20% | -297.10% | -22.35% |
| Normalized Basic EPS | -9.12% | 79.83% | 29.13% | -131.20% | 69.25% |
| EPS Diluted | -366.55% | 94.11% | 28.20% | -335.23% | -12.58% |
| Normalized Diluted EPS | -9.12% | 79.83% | 29.13% | -143.87% | 55.78% |
| Average Basic Shares Outstanding | -3.95% | -4.15% | 13.00% | 13.11% | 11.88% |
| Average Diluted Shares Outstanding | -3.95% | -4.15% | 13.00% | -19.57% | -22.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |